Skip to main content
Caplight Logo









Conflixis

Conflixis

Private
Dallas, TexasHealthcare & Life Scienceshttps://conflixis.com/

Last Round

Seed

Nov 8, 2024

Total Funding Raised

$4.48M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Conflixis is a business/productivity software company that has developed an AI-powered risk management platform for identifying and managing conflicts of interest, primarily for the healthcare industry.

Sector

Healthcare & Life Sciences

Verticals

Compliance & Risk, RegTech, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

conflict of interest managementCOIhealthcare complianceRegTechhealthcare SaaScompliance automationrisk scoringregulatory risk managementprovider transparencyOpen PaymentsStark Law complianceAnti-Kickback Statutehealthcare risk softwarecompliance techdisclosure management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Conflixis Comparables

Compare Conflixis with similar companies based on industry and business-model similarity.

Conflixis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ntracts, Inc.
75%
Ethico
69%
symplr
69%

Conflixis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 8, 2024
Pre SeedFeb 13, 2024

Key People

Founding team and executive leadership

Joseph Bergen

Co-Founder CTO

Founding Team

Vincent Wan

Co-Founder and COO

Founding Team

Conflixis Investors

Notable investors and investment history

Conflixis investors
InvestorRounds
SpringTime VenturesSeed
Origin Ventures GroupSeed
Mark VCSeed
Lerer HippeauSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 501% MoM to 3.6K.

  • Feb 28, 2025

    Judy Ringholz joins as Senior Managing Director.

Conflixis Filings

Explore SEC and related filing metadata, where available.

Conflixis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Conflixis's valuation, stock price, and market status.

Is Conflixis a public or private company?

Conflixis is a private company.

What is the current stock price of Conflixis?

Conflixis is a private company with no public stock price. No recent secondary market data is available.

How much is Conflixis worth (valuation)?

Valuation information for Conflixis is not publicly available.

Can I buy Conflixis stock?

Conflixis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Conflixis's last funding round?

Conflixis's most recent funding round was Seed on November 8, 2024.

Who are the main investors in Conflixis?

Key investors in Conflixis include Lerer Hippeau.

Will Conflixis IPO soon?

No public IPO plans have been announced for Conflixis.

How can I track Conflixis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Conflixis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDallas, Texas
Employee Range12
Year Founded2023
Last FundingNov 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?